The verdict
Our read at a glance.
Whether DSIP's older and contested research supports the sleep, stress, and recovery claims made for gray-market DSIP products.
- The signal
- Research on DSIP is mostly older and inconsistent, covering sleep, stress, pain, and withdrawal, with no clear, replicated clinical benefit. Whether it functions as a true natural sleep regulator has been questioned, and it is not approved for any use.
- The unknown
- Whether DSIP has any reliable effect on sleep or recovery in rigorous trials, and how its dated research applies to gray-market products of uncertain identity.
- Our read
- An old, contested sleep peptide with thin and inconsistent evidence, not a proven sleep aid. DSIP has a long history of research, but it never produced clear, replicated benefit, so its modern sleep and recovery claims rest on weak ground.
The mechanism
How it works.
DSIP (delta sleep-inducing peptide) is a small nine-amino-acid peptide first isolated from the blood of sleeping rabbits and named for an apparent sleep-promoting effect. It is proposed to act on brain pathways tied to sleep, stress, and pain, but no specific receptor or clear mechanism has been confirmed, and whether it even functions as a natural sleep regulator in the body is disputed. Its effects are hard to pin down precisely because the underlying mechanism is not established.
Safety & regulatory boundary
The consequential part.
DSIP is not an approved drug and is sold as a research chemical, where product identity and quality are uncertain. Its older research is mixed and does not establish sleep, stress, or recovery benefits. It should not be treated as a proven or approved sleep aid, and gray-market products are not the same as any studied preparation.
What's next
What we're watching.
Any modern controlled trials, clarification of its biology, and product-quality findings for gray-market DSIP.
Context
Why this is discussed.
DSIP is marketed for sleep and recovery, and its name and early history give it an aura of being a natural sleep peptide, which people often take as stronger evidence than exists.
The evidence base
20 cited references.
Registered trials8
ClinicalTrials.gov · PHASE3 · ACTIVE_NOT_RECRUITING · 2024-08-08
ClinicalTrials.gov · NA · NOT_YET_RECRUITING · 2026-07-01
ClinicalTrials.gov · PHASE2 · RECRUITING · 2026-04-30
ClinicalTrials.gov · PHASE4 · COMPLETED · 2022-06-01
ClinicalTrials.gov · NA · COMPLETED · 2025-03-01
ClinicalTrials.gov · NA · RECRUITING · 2026-04-24
ClinicalTrials.gov · NA · COMPLETED · 2017-03-01
ClinicalTrials.gov · NA · ACTIVE_NOT_RECRUITING · 2022-10-26
Indexed literature (PubMed)12
Pollard BJ et al. · Eur J Anaesthesiol · 2001
Kovalzon VM et al. · J Neurochem · 2006
Graf MV et al. · Peptides · 1986
Graf MV et al. · Neurosci Biobehav Rev · 1984
Rahman OF et al. · J Am Acad Orthop Surg Glob Res Rev · 2026
Susić V et al. · Brain Res · 1987
Nakamura A et al. · Eur J Pharmacol · 1988
Sahu A et al. · Life Sci · 1987
Ernst A et al. · J Neurol · 1987
Bjartell A et al. · Peptides · 1989
Banks WA et al. · Life Sci · 1983
Schneider-Helmert D et al. · Experientia · 1981
Keep reading